As of 2024-12-12, the Relative Valuation of Gilead Sciences Inc (GILD) is 41.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 92.38 USD, the upside of Gilead Sciences Inc based on Relative Valuation is -55.0%.
The range of the Relative Valuation is 1.54 - 86.22 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 21.6x | 16.8x |
| Forward P/E multiples | 16.9x - 19.0x | 18.0x |
| Fair Price | 1.54 - 86.22 | 41.60 |
| Upside | -98.3% - -6.7% | -55.0% |
| Date | P/E |
| 2024-12-11 | 921.04 |
| 2024-12-10 | 920.64 |
| 2024-12-09 | 903.20 |
| 2024-12-06 | 918.55 |
| 2024-12-05 | 931.11 |
| 2024-12-04 | 913.17 |
| 2024-12-03 | 922.14 |
| 2024-12-02 | 937.39 |
| 2024-11-29 | 923.04 |
| 2024-11-27 | 921.34 |
| 2024-11-26 | 910.77 |
| 2024-11-25 | 902.20 |
| 2024-11-22 | 899.21 |
| 2024-11-21 | 894.92 |
| 2024-11-20 | 883.66 |
| 2024-11-19 | 874.88 |
| 2024-11-18 | 881.96 |
| 2024-11-15 | 881.36 |
| 2024-11-14 | 918.35 |
| 2024-11-13 | 923.54 |
| 2024-11-12 | 940.68 |
| 2024-11-11 | 967.40 |
| 2024-11-08 | 962.77 |
| 2024-11-07 | 976.08 |
| 2024-11-06 | 914.16 |
| 2024-11-05 | 899.51 |
| 2024-11-04 | 895.72 |
| 2024-11-01 | 892.43 |
| 2024-10-31 | 885.55 |
| 2024-10-30 | 880.27 |
| 2024-10-29 | 878.17 |
| 2024-10-28 | 884.95 |
| 2024-10-25 | 887.34 |
| 2024-10-24 | 885.15 |
| 2024-10-23 | 869.70 |
| 2024-10-22 | 878.97 |
| 2024-10-21 | 860.33 |
| 2024-10-18 | 864.61 |
| 2024-10-17 | 870.99 |
| 2024-10-16 | 864.91 |
| 2024-10-15 | 855.64 |
| 2024-10-14 | 847.96 |
| 2024-10-11 | 846.97 |
| 2024-10-10 | 844.17 |
| 2024-10-09 | 858.83 |
| 2024-10-08 | 849.56 |
| 2024-10-07 | 841.78 |
| 2024-10-04 | 843.38 |
| 2024-10-03 | 839.19 |
| 2024-10-02 | 844.87 |